|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 53.03 USD | -5.25% |
|
-4.23% | +20.99% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Biotechnology | 1.43B | 1.61B | 1.83B | 2.17B | 2.32B | |||||
Total Assets | 2.62B | 3.07B | 2.94B | 2.95B | 2.84B | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | 63.09M | 52.07M | 49.76M | 160M | 159M | |||||
CAPEX | -64.22M | -27.71M | -40.47M | -28.44M | -8.43M | |||||
EBT | 294M | 234M | 258M | 682M | 941M | |||||
D&A | 13.63M | 20.88M | 25.72M | 28.8M | 29.06M | |||||
Operating Income | 287M | 201M | 171M | 605M | 872M | |||||
Net Income | 231M | 182M | 208M | 521M | 783M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States (U.S.) | 1.09B | 1.41B | 1.65B | 1.82B | 2.14B | |||||
Total Assets | 2.62B | 3.07B | 2.94B | 2.95B | 2.84B | |||||
Europe | 302M | 169M | 145M | 319M | 154M | |||||
Japan | 43.5M | 28.73M | 39.49M | 27.08M | 25.59M | |||||
Rest of The World | - | - | - | - | - |
- Stock Market
- Stocks
- EXEL Stock
- Financials Exelixis, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
